Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTiton Regulatory News (TON)

Share Price Information for Titon (TON)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
75.00
Ask:
85.00
Spread: 10.00 (13.333%)
Market Cap: £9.00m
TON Live PriceLast checked at - London Stock Exchange

Intraday Titon Share Chart

Hardman & Co Research: Electiton

17 Dec 2019 07:30

Hardman & Co Research Hardman & Co Research: Electiton 17-Dec-2019 / 07:30 GMT/BST


Hardman & Co Research: Electiton

'Tis rare that a company reports on the same day as a general election. Okay, Titon's gestation was the longer but the conclusions are the same. "It's over and yet it has only just begun". For Boris Johnson, this means actually 'getting Brexit done' and running the country. For Titon, it has just reported its full year in which it coped manfully with a number of travails; and now has to do the same in the next one and 'win the peace'. Boris's skill-set to deal with in-coming remains the subject of speculation. Not so Titon's.

https://www.hardmanandco.com/research/corporate-research/electiton/

 

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contacts:

Tony Williams 

+44 20 7194 7622

 

research@hardmanandco.com

 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

937487 17-Dec-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
1st Jun 20267:00 amRNSAcquisition
30th Apr 20267:00 amRNSInterim results
17th Apr 20267:00 amRNSNotice of Interim Results & Investor Presentation
20th Mar 20267:00 amRNSResult of AGM
19th Mar 20267:00 amRNSAGM Trading Update
23rd Feb 20267:00 amRNS2025 Annual Report and Notice of AGM
15th Jan 20267:00 amRNSAnnual Financial Report
2nd Dec 20257:00 amRNSDirector/PDMR Shareholding
24th Nov 20257:00 amRNSHolding(s) in Company
17th Oct 20257:00 amRNSFull Year Trading Update
29th Sep 20252:18 pmRNSHolding(s) in Company
29th Sep 202512:42 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSHolding(s) in Company
11th Jul 20259:10 amRNSHolding(s) in Company
7th Jul 20259:01 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSUnaudited Interim Results to 31 March 2025
25th Apr 20257:00 amRNSNotice of Interim Results & Investor Presentation
1st Apr 20257:00 amRNSHolding(s) in Company
25th Mar 20253:10 pmRNSResult of AGM
25th Mar 20257:00 amRNSAGM Trading Update
18th Mar 202512:03 pmRNSDirector/PDMR Shareholdings
3rd Mar 20257:00 amRNS2024 Annual Report and Notice of AGM
23rd Jan 20257:00 amRNSAnnual Financial Report
20th Jan 20257:00 amRNSNotice of Results and Investor Presentation
16th Dec 20247:00 amRNSCompletion of Disposal and Update on FY24 Results
29th Oct 20241:46 pmRNSDirector/PDMR Shareholdings
24th Oct 20247:00 amRNSCommencement of Process to Dispose of Korean Ops
3rd Sep 20247:00 amRNSNon-Executive Board Change
19th Jul 20242:05 pmRNSGrant of options and Director/PDMR Shareholding
11th Jul 20247:00 amRNSTrading Update and Board Change
15th May 20247:00 amRNSInterim Results for six months to 31 March 2024
25th Apr 20247:00 amRNSNotice of Interim Results & Investor Presentation
17th Apr 20242:15 pmRNSNotification of Major Holdings
2nd Apr 20242:43 pmRNSHolding(s) in Company
27th Mar 202411:28 amRNSResult of Annual General Meeting
26th Mar 20247:00 amRNSAGM Trading Update
27th Feb 20245:00 pmRNSDirector/PDMR Shareholding
26th Feb 20243:15 pmRNS2023 Annual Financial Report and Notice of AGM
25th Jan 20247:00 amRNSAnnual Financial Report year ended 30 Sept 2023
19th Jan 20241:07 pmRNSInvestor Presentation via Investor Meet Company
22nd Dec 20237:00 amRNSConfirmation of Board Appointment
5th Dec 20237:00 amRNSNotification of Major Holdings
4th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSNon-Executive Director Changes
22nd Nov 20237:00 amRNSAppointment of CEO
6th Oct 20234:00 pmRNSExercise of Options and Total Voting Rights
14th Sep 20233:45 pmRNSHolding(s) in Company
30th Aug 20232:17 pmRNSNotification of Major Holdings
4th Jul 20234:30 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.